Czechia vs Venezuela, Bolivarian Republic of: TB patients with known HIV status
Czechia
71.0%
in 2024
Venezuela, Bolivarian Republic of
69.0%
in 2024
Czechia rank
148th
Venezuela, Bolivarian Republic of rank
151st
TB patients with known HIV status over time
- Czechia
- Venezuela, Bolivarian Republic of
How they compare
Czechia currently reports 71.0% against 69.0% in Venezuela, Bolivarian Republic of, a difference of 2.0%.
The two have swapped places 1 time across 21 shared years of data; in 2004 it was Venezuela, Bolivarian Republic of ahead.
Czechia ranks 148th and Venezuela, Bolivarian Republic of ranks 151st of 181 countries.
Across the 3 decades both report, Czechia averaged higher in 1 and Venezuela, Bolivarian Republic of in 2.
Head to head by decade
| Decade | Czechia | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.8% | 51.8% | 32.0% | Venezuela, Bolivarian Republic of |
| 2010s | 34.3% | 64.0% | 29.7% | Venezuela, Bolivarian Republic of |
| 2020s | 63.4% | 52.4% | 11.0% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tb patients with known hiv status, Czechia or Venezuela, Bolivarian Republic of?
- Czechia, at 71.0% against 69.0% in Venezuela, Bolivarian Republic of as of 2024.
- What is the difference in tb patients with known hiv status between Czechia and Venezuela, Bolivarian Republic of?
- 2.0%, with Czechia ahead.
- How many years of comparable data are there for Czechia and Venezuela, Bolivarian Republic of?
- 21 years are reported by both, from 2004 to 2024.
- How do Czechia and Venezuela, Bolivarian Republic of rank globally for tb patients with known hiv status?
- Czechia ranks 148th and Venezuela, Bolivarian Republic of ranks 151st of 181 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as TB patients with known HIV status (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.